10/19/14
New Issue
PFENEX INC(PFNX), TRAVELPORT WORLDWIDE(TVPT), CONE MIDSTREAM PARTNERS(CNNX), SMART & FINAL STORES(SFS), MEDLEY MANAGEMENTMDLY), ISRAEL CHEMICALS(ICL), CITIZENS FINANCIAL GROUP(CFG), GRUPO AVAL ACCIONES Y VALORES(AVAL), ALIBABA GROUP HOLDING(BABA), CIVITAS SOLUTIONS(CIVI), C1 FINANCIAL(BNK), RYERSON HOLDING CORP(RYI), INDEPENDENCE CONTRACT DRILLING(ICD), HOEGH LNG PARTNERS(HMLP), VTTI ENERGY PARTNERS(VTTI), MOBILEYE N.V.(MBLY), FCB FINANCIAL HOLDINGS(FCB), SYNCHRONY FINANCIAL(SYF), TRANSOCEAN PARTNERS(RIGP), CATALENT, INC(CTLT), WESTLAKE CHEMICAL PARTNERS(WLKP), ADVANCED DRAINAGE SYSTEMS(WMS), ORION ENGINEERED CARBONS S.A.(OEC), TOWNSQUARE MEDIA(TSQ), TRUPANION INC(TRUP), GLOBANT S.A.(GLOB), MINERVA NEUROSCIENCES(NERV), INVESTAR HOLDING(ISTR), GLOBEIMMUNE INC(GBIM), 1347 CAPITAL CORP(TFSCU), IRADIMED CORP(IRMD), CAREDX(CDNA), ROKA BIOSCIENCE(ROKA), TERRAPIN 3 ACQUISITION CORP(TRTLU), TERRAFORM POWER(TERP), TUBEMOGUL INC(TUBE), SAGE THERAPEUTICS(SAGE), MEDICAL TRANSCRIPTION BILLING(MTBC), IMMUNE DESIGN(IMDZ), INTERSECT ENT(XENT), OCULAR THERAPEUTIX(OCUL), EL POLLO LOCO HOLDING(LOCO), INNOCOLL AG(INNL), CONTRAFECT CORP(CFRXU), SPARK ENERGY(SPKE), BIO BLAST PHARMA(ORPN), MARINUS PHARMACEUTICAL(MRNS), MACROCURE(MCUR), HEALTHEQUITY(HQY), AVALANCHE BIOTECHNOLOGIES(AAVL), LOXO ONCOLOGY(LOXO), AURIS MEDICAL HOLDING(EARS), T2 BIOSYSTEMS(TTOO), IDREAMSKY TECHNOLOGY(DSKY), GREEN BANCORP(GNBC), OTONOMY, INC(OTIC), SINO MERCURY ACQUISITION CORP(SMACU), GWG HOLDING(GWGH), VITAE PHARMACEUTICAL(VTAE), PROQR THERAPEUTICS(PRQR), FOAMIX PHARMACEUTICAL(FOMX), TOKAI PHARMACEUTICAL(TKAI), REWALK ROBOTICS (RWLK), AFFIMED N.V.(AFMD)